Cliffside Park Imaging is categorized under Medical X-Ray Laboratories in Cliffside Park, NJ .
Cliffside Park Imaging was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Medical X-Ray Laboratories business, which does work in the B2C market, and is classified as a Medical X-Ray Laboratories, under code number 6215120 by the NAICS.
If you are seeking more information, feel free to contact Michael Davit, Owner at the company’s single location by writing to 596 Anderson Avenue # 120, Cliffside Park, New Jersey NJ 07010 or by phoning (201) 945-6747. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cliffside Park Imaging |
| Contact Person: | Michael Davit, Owner |
| Address: | 596 Anderson Avenue # 120, Cliffside Park, New Jersey 07010 |
| Phone Number: | (201) 945-6747 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical X-Ray Laboratories |
| SIC Code: | 8071 |
| NAICS Code: | 6215120 |
| Share This Business: |
Cliffside Park Imaging was started in 0 to provide professional Medical X-Ray Laboratories under the SIC code 8071 and NAICS code 6215120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Michael Davit, Owner for inquiries that concern Cliffside Park Imaging by calling the company number (201) 945-6747, as your correspondence is most welcome. Additionally, the physical location of the single location of Cliffside Park Imaging can be found at the coordinates 40.824551,-73.988353 as well as the street address 596 Anderson Avenue # 120 in Cliffside Park, New Jersey 07010.
For its online presence, you may visit Cliffside Park Imaging’s website at and engage with its social media outlets through on Twitter and on Facebook.